Lintuzumab (Anti-Siglec-3 / CD33)Lintuzumab (Anti-Siglec-3 / CD33)
Move your mouse over image or click to enlarge

Lintuzumab (Anti-Siglec-3 / CD33)

Lintuzumab (HuM195) is a humanized monoclonal antibody that targets CD33, a 67-kDa cell surface glycoprotein expressed on most myeloid leukemia cells. MW: 145. 24 kD.
Cat# Size Price Qty Buy
A2760-1mg*25 1mg*25
£4,152.00
A2760-1mg*5 1mg*5
£1,384.00
A2760-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2760

Related Documents